# Cluster3-12 Analysis

## Proteins: 

ARMC5, CCDC138, CCNC, CDK19, CDK8, CTDP1, DNAAF10, GPN1, GPN3, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PCF11, PDZK1, PIN1, POLR1D, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2H, POLR2I, POLR2L, POLR2M, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, PTPN12, RECQL5, RPAP1, RPAP2, RSU1, SAFB, SKAP1, SUPT6H, URI1, UXT

### Nucleoplasmic RNA Polymerase and Mediator Complex System

**Summary**

The analyzed human protein system comprises a set of proteins that are predominantly involved in transcription regulation, particularly in the context of RNA polymerase II and III complexes and the mediator complex. The majority of these proteins are localized in the nucleoplasm and nucleus, with some also found in the cytosol and other cellular compartments. Key biological processes performed by this system include transcription initiation, elongation, and termination by RNA polymerase II and III, as well as the assembly of preinitiation complexes and core mediator complexes. Given the cellular location and function of these proteins, we propose the name "Nucleoplasmic RNA Polymerase and Mediator Complex System" for this protein system.

**References**

1. Allen, B. L., & Taatjes, D. J. (2015). The Mediator complex: a central integrator of transcription. Nature Reviews Molecular Cell Biology, 16(3), 155-166. [DOI: 10.1038/nrm3951](https://doi.org/10.1038/nrm3951)

2. Cramer, P. (2019). Eukaryotic transcription turns 50. Cell, 179(4), 808-812. [DOI: 10.1016/j.cell.2019.10.014](https://doi.org/10.1016/j.cell.2019.10.014)

3. Jeronimo, C., & Robert, F. (2017). The Mediator complex: at the nexus of RNA polymerase II transcription. Trends in Cell Biology, 27(10), 765-783. [DOI: 10.1016/j.tcb.2017.07.001](https://doi.org/10.1016/j.tcb.2017.07.001)

4. Sainsbury, S., Bernecky, C., & Cramer, P. (2015). Structural basis of transcription initiation by RNA polymerase II. Nature Reviews Molecular Cell Biology, 16(3), 129-143. [DOI: 10.1038/nrm3952](https://doi.org/10.1038/nrm3952)

5. Vannini, A., & Cramer, P. (2012). Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Molecular Cell, 45(4), 439-446. [DOI: 10.1016/j.molcel.2012.01.023](https://doi.org/10.1016/j.molcel.2012.01.023)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 52 | RSU1, PIN1, SUPT6H, PTPN12, RPAP2, SAFB, DNAAF10, ARMC5, CTDP1, GPN1, GPN3, POLR1D, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2I, POLR2L, POLR3A, POLR3C, POLR3F, POLR3G, POLR3H, POLR3K, RPAP1, SKAP1, URI1, UXT, CCNC, CDK8, ILK, MED1, MED12, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PDZK1 |
| nucleoplasm | 49 | PIN1, SUPT6H, PTPN12, RPAP2, SAFB, ARMC5, CTDP1, GPN1, PCF11, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2H, POLR2I, POLR2L, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, RECQL5, SKAP1, URI1, UXT, CCNC, CDK19, CDK8, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6 |
| nucleus | 42 | PIN1, PTPN12, RPAP2, SAFB, CTDP1, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2H, POLR2I, POLR2L, POLR3A, POLR3G, RECQL5, RPAP1, URI1, UXT, CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| cytosol | 25 | RSU1, PIN1, PTPN12, RPAP2, ARMC5, GPN1, POLR2C, POLR2D, POLR2E, POLR2H, POLR2L, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, RECQL5, SKAP1, URI1, CDK19, ILK, MED27 |
|  transcription by RNA polymerase II | 22 | PIN1, RPAP2, SAFB, CTDP1, SKAP1, URI1, CCNC, CDK8, MED1, MED12, MED13, MED14, MED17, MED18, MED21, MED23, MED25, MED27, MED29, MED31, MED4, MED6 |
| mediator complex | 22 | CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
|  transcription initiation by RNA polymerase II | 19 | MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
|  transcription elongation by RNA polymerase II | 18 | SUPT6H, MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| RNA polymerase II preinitiation complex assembly | 17 | MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| core mediator complex | 17 | MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| transcription coregulator activity | 14 | MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED29, MED30, MED31, MED4, MED9 |
| cytoplasm | 13 | PIN1, PTPN12, RPAP2, ARMC5, CTDP1, PCF11, POLR2A, RECQL5, SKAP1, URI1, UXT, MED15, MED22 |
| DNA binding | 13 | SUPT6H, POLR1D, POLR2A, POLR2B, POLR2C, POLR2E, POLR2L, POLR3A, POLR3D, POLR3H, RPAP1, MED1, MED6 |
| membrane | 13 | ARMC5, POLR2B, POLR3A, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED28, MED4, MED6 |
| RNA polymerase III complex | 12 | POLR1D, POLR2E, POLR2H, POLR2L, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K |
| RNA polymerase III activity | 11 | POLR1D, POLR2E, POLR2H, POLR2L, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3H, POLR3K |
| transcription by RNA polymerase III | 11 | POLR1D, POLR2E, POLR2H, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K |
| DNA-directed 5'-3' RNA polymerase activity | 11 | POLR2A, POLR2E, POLR2I, POLR2L, POLR3A, POLR3C, POLR3F, POLR3G, POLR3H, POLR3K, MED21 |
|  DNA-templated transcription | 11 | POLR2A, SKAP1, ILK, MED1, MED12, MED13, MED14, MED17, MED23, MED30, MED4 |
| transcription by RNA polymerase II | 11 | POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2H, POLR2I, POLR2L, RPAP1, MED4 |
| transcription coactivator activity | 11 | MED1, MED12, MED13, MED14, MED17, MED21, MED23, MED27, MED30, MED4, MED6 |
| RNA polymerase II, core complex | 10 | POLR2M, POLR2A, POLR2B, POLR2C, POLR2D, POLR2E, POLR2G, POLR2H, POLR2I, POLR2L |
| chromatin binding | 9 | SAFB, POLR2B, POLR3A, POLR3D, POLR3G, URI1, UXT, MED1, MED12 |
| defense response to virus | 9 | ARMC5, POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K |
| somatic stem cell population maintenance | 9 | MED12, MED14, MED15, MED17, MED21, MED27, MED28, MED30, MED6 |
| innate immune response | 8 | POLR3A, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K |
| nucleolus | 7 | RPAP2, POLR2A, POLR2I, POLR3K, CDK8, MED1, MED27 |
| nuclear receptor coactivator activity | 7 | MED1, MED12, MED13, MED14, MED17, MED30, MED4 |
| nuclear vitamin D receptor binding | 7 | MED1, MED12, MED13, MED14, MED17, MED30, MED4 |
| RNA polymerase II activity | 6 | POLR2A, POLR2B, POLR2C, POLR2E, POLR2H, POLR2L |
| transcription initiation at RNA polymerase II promoter | 6 | POLR2D, POLR2G, POLR2I, MED17, MED23, MED27 |
| nuclear thyroid hormone receptor binding | 6 | MED1, MED12, MED13, MED17, MED30, MED4 |
| protein stabilization | 5 | PIN1, DNAAF10, POLR2E, URI1, UXT |
|  interferon-beta production | 5 | POLR3A, POLR3C, POLR3D, POLR3F, POLR3G |
| ubiquitin protein ligase activity | 5 | MED12, MED17, MED27, MED30, MED31 |
| protein ubiquitination | 5 | MED12, MED17, MED27, MED30, MED31 |
| ubiquitin ligase complex | 5 | MED12, MED17, MED27, MED30, MED31 |
| focal adhesion | 4 | RSU1, PTPN12, ARMC5, ILK |
| RNA binding | 4 | SUPT6H, SAFB, POLR2A, POLR2B |
| metal ion binding | 4 | RPAP2, POLR2A, POLR2B, POLR3A |
| RPAP3/R2TP/prefoldin-like complex | 4 | DNAAF10, POLR2E, URI1, UXT |
| RNA polymerase I activity | 4 | POLR1D, POLR2E, POLR2H, POLR2L |
| transcription by RNA polymerase I | 4 | POLR1D, POLR2E, POLR2H, POLR2L |
| RNA polymerase I complex | 4 | POLR1D, POLR2E, POLR2H, POLR2L |
|  innate immune response | 4 | POLR3C, POLR3D, POLR3F, POLR3G |
| ATP binding | 4 | RECQL5, CDK19, CDK8, ILK |
| negative regulation of transcription by RNA polymerase II | 4 | URI1, UXT, MED1, MED25 |
| transcription regulator complex | 4 | MED17, MED23, MED25, MED27 |
|  gene expression | 3 | PIN1, MED1, MED23 |
| midbody | 3 | PIN1, SAFB, CTDP1 |
| transcription preinitiation complex | 3 | RPAP2, POLR2M, RECQL5 |
| centrosome | 3 | CTDP1, POLR3H, UXT |
| protein-containing complex | 3 | CTDP1, GPN3, CDK8 |
| mitochondrion | 3 | GPN1, PCF11, URI1 |
| RNA polymerase II complex binding | 3 | PCF11, RECQL5, URI1 |
| single-stranded DNA binding | 3 | POLR2G, POLR2H, POLR3C |
| nucleic acid binding | 3 | POLR2I, POLR3K, RECQL5 |
| zinc ion binding | 3 | POLR2I, POLR2L, POLR3K |
| DNA-templated transcription | 3 | POLR3A, MED12, MED13 |
|  transcription by RNA polymerase III | 3 | POLR3C, POLR3F, POLR3G |
| plasma membrane | 3 | SKAP1, ILK, PDZK1 |
| transcription corepressor activity | 3 | URI1, UXT, MED1 |
| protein serine kinase activity | 3 | CDK19, CDK8, ILK |
| protein phosphorylation | 3 | CDK19, CDK8, ILK |
| transcription coactivator binding | 3 | MED1, MED25, MED6 |
|  GTPase activity | 2 | RSU1, PIN1 |
| extracellular exosome | 2 | RSU1, PDZK1 |
| beta-catenin binding | 2 | PIN1, MED12 |
| phosphoprotein binding | 2 | PIN1, URI1 |
|  protein phosphorylation | 2 | PIN1, ILK |
|  canonical Wnt signaling pathway | 2 | PIN1, ILK |
| nuclear speck | 2 | PIN1, POLR2D |
| transcription elongation by RNA polymerase II | 2 | SUPT6H, CTDP1 |
| mRNA transcription by RNA polymerase II | 2 | SUPT6H, MED1 |
|  mRNA processing | 2 | SUPT6H, SAFB |
| phosphoprotein phosphatase activity | 2 | PTPN12, CTDP1 |
| SH3 domain binding | 2 | PTPN12, SKAP1 |
| protein dephosphorylation | 2 | PTPN12, CTDP1 |
| cellular response to epidermal growth factor stimulus | 2 | PTPN12, MED1 |
| RNA polymerase II CTD heptapeptide repeat phosphatase activity | 2 | RPAP2, CTDP1 |
| myosin phosphatase activity | 2 | RPAP2, CTDP1 |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2 | SAFB, MED12 |
| double-stranded DNA binding | 2 | SAFB, POLR3F |
| apoptotic process | 2 | DNAAF10, UXT |
| cell division | 2 | CTDP1, RECQL5 |
| spindle pole | 2 | CTDP1, UXT |
| intracellular membrane-bounded organelle | 2 | CTDP1, POLR3H |
| GTPase activity | 2 | GPN1, GPN3 |
| GTP binding | 2 | GPN1, GPN3 |
| termination of RNA polymerase II transcription | 2 | PCF11, MED18 |
| mRNA cleavage | 2 | PCF11, POLR2I |
| protein dimerization activity | 2 | POLR1D, POLR2C |
| promoter-specific chromatin binding | 2 | POLR2A, MED1 |
| chromosome | 2 | POLR2A, RECQL5 |
| translation initiation factor binding | 2 | POLR2D, POLR2G |
| protein kinase binding | 2 | SKAP1, ILK |
| protein localization to plasma membrane | 2 | SKAP1, PDZK1 |
| cellular response to steroid hormone stimulus | 2 | URI1, MED1 |
| protein folding chaperone complex | 2 | URI1, UXT |
| G0 to G1 transition | 2 | CCNC, MED1 |
| cyclin-dependent protein serine/threonine kinase activity | 2 | CDK19, CDK8 |
|  cell cycle | 2 | CDK19, CDK8 |
| cell morphogenesis | 2 | ILK, MED1 |
| nuclear retinoic acid receptor binding | 2 | MED1, MED25 |
| protein-containing complex binding | 2 | MED1, PDZK1 |
| transcription factor binding | 2 | MED12, MED29 |
| negative regulation of fibroblast proliferation | 2 | MED25, MED31 |

